Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care - ANCHOR

Study identifier:D6930L00001

ClinicalTrials.gov identifier:NCT06422689

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

ANCHOR - Assessment of Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

Medical condition

asthma

Phase

Phase 4

Healthy volunteers

No

Study drug

Albuterol and budesonide inhalation aerosol

Sex

All

Estimated Enrollment

2000

Study type

Interventional

Age

18 Years - 130 Years

Date

Study Start Date: 10 May 2024
Estimated Primary Completion Date: 29 Apr 2026
Estimated Study Completion Date: 29 Apr 2026

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: -
Primary Purpose: Treatment

Verification:

Verified 01 Sept 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

Premier HealthCare Solutions Inc.

Inclusion and exclusion criteria